In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human Primates-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human Primates

Published:2014-05-28 Issue:9 Volume:2 Page:846-856
ISSN:2326-6066
Container-title:Cancer Immunology Research
language:en
Short-container-title:Cancer Immunol Res

Author:

Wang Changyu,Thudium Kent B.,Han Minhua,Wang Xi-Tao,Huang Haichun,Feingersh Diane,Garcia Candy,Wu Yi,Kuhne Michelle,Srinivasan Mohan,Singh Sujata,Wong Susan,Garner Neysa,Leblanc Heidi,Bunch R. Todd,Blanset Diann,Selby Mark J.,Korman Alan J.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Immunology

Cited by 529 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell-Int: a cell–cell interaction assay to identify native membrane protein interactions;Life Science Alliance;2024-09-05

2. Emerging Immune Checkpoint Inhibitors for the Treatment of Oropharyngeal Squamous Cell Carcinoma;Oral Oncology Reports;2024-09

3. A Novel Monoclonal Antibody against PD-1 for the Treatment of Viral Oncogene-Induced Tumors or Other Cancer;Cancers;2024-09-01

4. Translate Pharmacokinetics of PD-1/PD-L1 Monoclonal Antibodies from Cynomolgus Monkey to Human: Comparison of Different Approaches;Journal of Pharmaceutical Sciences;2024-09

5. A novel anti-FGFR1 monoclonal antibody OM-RCA-01 exhibits potent antitumor activity and enhances the efficacy of immune checkpoint inhibitors in lung cancer models;Immuno-Oncology and Technology;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP